人THRA变异在斑马鱼中表达的体内功能后果
本研究在斑马鱼胚胎中表达多种人甲状腺激素受体α(hTRα)变异体并分析表型。所有注射hTRα的胚胎出现脑和心脏水肿、贫血、血管网络形成不全、运动神经元和颅面发育缺陷,影响自主摄食和游泳行为;所有hTRα突变体对促甲状腺激素β和促甲状腺激素释放激素转录本无 detectable 影响。高剂量三碘甲状腺原氨酸仅能有效逆转错义hTRα变异体注射胚胎的缺陷。
要点
- 注射人THRA变异的斑马鱼胚胎出现组织特异性缺陷,重现RTHα多数临床和生化表现。
- 所有hTRα突变体对下丘脑/垂体水平促甲状腺激素β2靶点的显性负性作用有限。
- 高剂量三碘甲状腺原氨酸仅能有效逆转错义hTRα变异体注射胚胎的缺陷。
核心结论
- 在斑马鱼胚胎中注射人THRA变异体引起组织特异性缺陷,重现大多数RTHα临床和生化表现。
- 该操作代表一种新的体内模型,用于筛选THRA变异的功能后果和新治疗化合物的挽救潜力。
研究设计与样本
- 本研究在斑马鱼胚胎中表达几种人甲状腺激素受体α(hTRα)变异体并分析所得表型。
主要发现
- 所有注射hTRα的胚胎显示可变缺陷,包括可能由心脏发育异常环化引起的脑和心脏水肿、贫血及血管网络形成不全。
- 注射hTRα的胚胎还表现出运动神经元和颅面发育严重缺陷,从而影响其自主摄食和游泳行为。
- 所有hTRα突变体的表达对促甲状腺激素β和促甲状腺激素释放激素转录本无 detectable 影响,表明其显性负性作用在体内对下丘脑/垂体水平甲状腺激素受体β2靶点有限。
- 如先前体外描述,高剂量三碘甲状腺原氨酸治疗仅能有效逆转错义hTRα变异体注射胚胎的缺陷。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heterozygous mutations in the thyroid hormone receptor alpha (THRA) gene cause resistance to thyroid hormone alpha (RTHα), a disease characterized by variable manifestations reminiscent of untreated congenital hypothyroidism but a raised triiodothyronine/thyroxine ratio and normal thyrotropin levels. It was recently described that zebrafish embryos expressing a dominant negative (DN) form of thraa recapitulate the key features of RTHα, and that zebrafish and human receptors are functionally interchangeable. METHODS: This study expressed several human thyroid hormone receptor alpha (hTRα) variants in zebrafish embryos and analyzed the resulting phenotypes. RESULTS: All hTRα-injected embryos showed variable defects, including cerebral and cardiac edema likely caused by an aberrant looping during heart development, anemia, and an incomplete formation of the vascular network. Moreover, the hTRα-injected embryos presented severe defects of motorneurons and craniofacial development, thus affecting their autonomous feeding and swimming behaviors. Surprisingly, expression of all hTRα mutants had no detectable effect on thyrotropin beta and thyrotropin-releasing hormone transcripts, indicating that their DN action is limited on the thyroid hormone reception beta 2 targets at the hypothalamic/pituitary level in vivo. As previously described in vitro, treatment with high triiodothyronine doses can efficiently revert the observed defects only in embryos injected with missense hTRα variants. CONCLUSION: Injection of human THRA variants in zebrafish embryos causes tissue-specific defects recapitulating most of the RTHα clinical and biochemical manifestations. The described manipulation of zebrafish embryos represents a novel in vivo model to screen the functional consequences of THRA variants and the rescue potential of new therapeutic compounds.
引用
- Marelli F, Carra S, Rurale G, et al. In vivo Functional Consequences of Human THRA Variants Expressed in the Zebrafish. Thyroid. 2016. PMID: 27809680. doi:10.1089/thy.2016.0373
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。